Are Aortic Stenosis and Kidney Dysfunction Associated?

Courtesy of Dr. Carlos Fava.

Aortic stenosis happens in 2.8% of patients over 75, and is even more frequent in dialysis patients. However, it remains unclear whether kidney dysfunction increases the risk of aortic stenosis.

The present study looked at 1,121,875 patients from the SCREAM project (Stockholm CREAtinine Measurements).

 

Mean age was 50, and 54% of the population were women. 16.2% of patients suffered from hypertension, hyperlipidemia 9.9%, diabetes 5.5%, ischemic cardiomyopathy 5.3% and stroke 3%. Estimated glomerular filtration rate (eGFR) was 96 ml/min/1.73 m2 (IQR: 82 to 109 ml/min/1.73 m2).


Read also: Outcomes of Contemporary DES in Patients with Diabetes: Do They Render Freedom Obsolete?


Patients were divided according to GFR: 699,957 presented >90 eGFR, ml/min/1.73 m2; 354,969 between 60-90; 44,744 between 45-59; 16,611 between 30-44; and 5,594 <30.

 

Patients presenting the lowest eGFR were mostly women, had more comorbidities and required more medication.

 

Follow up was at 5.1 years. 5,858 patients developed aortic stenosis, that is, there was an incidence of 1.13 every 1000 person/year. Patients presenting eGFR >90 ml/min/1.73 m2 were 0.34 every 1000 person/year, increasing as eGFR decreased, reaching 8.27 in those presenting eGFR <30 ml/min/1.73 m2.


Read also: The Price of Binge Watching: Subclinical Atherosclerosis and Sleep Quality.


Patients with eGFR ≤44 ml/min/1.73 m2 presented approximately 20% higher risk of developing aortic stenosis, even excluding those that had had events or cardiac failure.

 

Conclusion

Moderate to severe chronic kidney dysfunction is associated to increased risk of aortic stenosis.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Kidney Dysfunction and the Risk of Developing Aortic Stenosis.

Reference: Georgios Vavilis, et al. J Am Coll Cardiol 2019;73:305–14.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...